2/23/2024  9:59:59 PM Chg. +0.35 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
51.66USD +0.68% 347,414
Turnover: 17.93 mill.
-Bid Size: - -Ask Size: - 104.47 bill.USD 4.47% 13.31

Business description

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
 

Management board & Supervisory board

CEO
Giovanni Caforio
Management board
David Elkins, Chris Boerner, Pamela Fisher, Cari Gallman, Samit Hirawat, Adam Lenkowsky, Sandra Leung, Greg Meyers, Elizabeth A. Mily, Peter S. Paine III, Robert Plenge, Ann M. Powell, Karin Shanahan, Estelle Vester-Blokland
Supervisory board
Giovanni Caforio, Derica W. Rice, Dr. Karen H. Vousden, Julia A. Haller, Manuel Hidalgo Medina, Paula A. Price, Peter J. Arduini, Phyllis Yale, Theodore R. Samuels, Gerald L. Storch, Chris Boerner, Deepak L. Bhatt
 

Company data

Name: Bristol-Myers Squibb Co.
Address: 430 E. 29th Street, 14FL,New York, New York 10016 USA
Phone: +1-212-546-4000
Fax: +1-212-546-4020
E-mail: -
Internet: www.bms.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: -
IPO date: 1/3/1972

Investor relations

Name: Tim Power
IR phone: +1-609-252-7509
IR Fax: -
IR e-mail: Investor.Relations@bms.com

Company calendar

CW 17 | 4/25/2024 Interim Report 1st Quarter/3 Months
CW 30 | 7/26/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 10/31/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
60.83%
Vanguard Group Inc
 
9.75%
Blackrock Inc.
 
8.27%
JP Morgan Chase & Company
 
4.95%
State Street Corporation
 
4.43%
Capital International Investors
 
3.32%
FMR, LLC
 
2.24%
Geode Capital Management, LLC
 
1.87%
Morgan Stanley
 
1.67%
Others
 
2.67%